163298-74-6 Usage
Primary use
Precursor for azo dyes synthesis 2-(methylamino)-3-nitrophenol is mainly used as a starting material in the production of azo dyes, which are a class of organic dyes used in various industries.
Physical appearance
Yellow crystalline solid This describes the color and form of the compound, which is a yellow-colored solid with a crystalline structure.
Melting point
88-92°C The temperature range at which 2-(methylamino)-3-nitrophenol transitions from a solid to a liquid state.
Solubility
Soluble in water, ethanol, and acetone This indicates that the compound can dissolve in these three solvents, which may be important for its handling and use in various applications.
Environmental hazard
Toxicity to aquatic organisms 2-(methylamino)-3-nitrophenol poses a risk to the environment due to its potential harmful effects on aquatic life.
Handling and disposal
Careful handling and disposal required To minimize the negative impact on the environment, it is essential to handle and dispose of this compound with caution and follow appropriate safety guidelines.
Check Digit Verification of cas no
The CAS Registry Mumber 163298-74-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,2,9 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 163298-74:
(8*1)+(7*6)+(6*3)+(5*2)+(4*9)+(3*8)+(2*7)+(1*4)=156
156 % 10 = 6
So 163298-74-6 is a valid CAS Registry Number.
163298-74-6Relevant articles and documents
Compounds enhancing antitumor activity of other cytotoxic agents
-
, (2008/06/13)
This invention relates to certain heterocyclic compounds and their pharmaceutically acceptable salts, which are useful for sensitizing multidrug-resistant tumor cells to anticancer agents and multidrug resistant forms of malaria, tuberculosis, leishmania and amoebic dysentery to chemotherapeutants. The compounds and their pharmaceutically acceptable salts are also inhibitors of the active drug transport capability of P-glycoprotein which is encoded by the human MDR1 gene, as well as of certain other related ATP-binding-cassette transporters from eukaryotic and prokaryotic organisms (e.g., pfmdr from Plasmodium falciprum, and murine mdr1 and mdr3 gene products).
